Cycrin Medroxyprogesterone for Menstrual and Endometrial Care

Cycrin contains medroxyprogesterone acetate, a progestin prescribed for selected menstrual and uterine conditions. Depending on the individual treatment plan, it may be used for secondary amenorrhea, abnormal uterine bleeding due to hormonal imbalance after other causes have been evaluated, or to reduce the risk of endometrial hyperplasia in certain postmenopausal patients receiving estrogen. Cycrin is not a contraceptive unless a clinician has prescribed a specific contraceptive formulation, and it should not be used to self-diagnose menstrual irregularity. Cycrin price varies by strength, quantity, pharmacy, and coverage, but cost does not determine whether hormonal treatment is appropriate.

Unexpected bleeding can have many causes, including pregnancy, miscarriage, infection, structural uterine conditions, medication effects, and cancer. Seek prompt medical advice for bleeding after menopause, heavy bleeding that soaks pads or tampons quickly, fainting, severe pelvic pain, pregnancy concerns, or bleeding accompanied by fever. A clinician should determine the cause before medroxyprogesterone is started or renewed.

Indications

Cycrin may be prescribed when a licensed clinician determines that progestin treatment is appropriate for the specific diagnosis and treatment goal. It is not intended for undiagnosed vaginal bleeding. Patients should buy Cycrin only with a valid prescription and after their prescriber has considered pregnancy status, medical history, current medicines, and any relevant examination or test results. Do not use another person's tablets or continue an old prescription without review.

When estrogen is used after menopause, a progestin may be included for people with a uterus to reduce the risk of estrogen-related endometrial overgrowth. That decision is individualized and requires periodic reassessment of benefits and risks. Obtain it from a regulated pharmacy that can verify the strength, instructions, and current prescription.

Dosage

Take Cycrin exactly as prescribed. The dose, tablet strength, timing within the menstrual cycle, and number of consecutive days of treatment depend on the indication and cannot be selected from general information. Medroxyprogesterone acetate tablets may be available in strengths such as 2.5 mg, 5 mg, and 10 mg, but these strengths and schedules are not interchangeable. Patients with a valid prescription can buy Cycrin 2.5 mg, 5 mg, or 10 mg only when the exact strength and regimen match the written directions.

Do not start on a different cycle day, change the number of treatment days, take more tablets, or stop treatment because bleeding changes without speaking with the prescriber. If a dose is missed, follow the prescription instructions or ask a pharmacist; do not double the next dose. Cycrin price may differ between strengths, but a less expensive strength must not be substituted without professional approval. Keep scheduled follow-up and report changes in bleeding, mood, headaches, or other symptoms.

Safety Information

Do not use Cycrin during known or suspected pregnancy. It is generally contraindicated in people with undiagnosed abnormal genital bleeding, known or suspected hormone-sensitive malignancy, active or prior serious thromboembolic disease when applicable, significant liver disease, or hypersensitivity to the product; the prescriber must assess the individual situation. Smoking can increase cardiovascular and clot-related risks, particularly in people with other risk factors. Discuss smoking cessation support with a clinician.

Seek emergency care for chest pain, shortness of breath, coughing blood, sudden severe headache, fainting, new weakness or numbness on one side, sudden vision or speech changes, or painful swelling and warmth in a leg. Promptly report jaundice, severe abdominal pain, new breast lump, marked depression, migraine changes, persistent or unusual vaginal bleeding, or signs of an allergic reaction. Patients who buy Cycrin should tell the prescriber about heart disease, hypertension, diabetes, high cholesterol or triglycerides, kidney disease, epilepsy, asthma, migraine, lupus, thyroid disease, recent surgery, prolonged immobility, and family or personal clotting history. Cost must not lead to skipped monitoring or unsupervised continued use.

Interactions

Tell the prescriber and pharmacist about every prescription medicine, nonprescription medicine, vitamin, and herbal product. Medicines that alter liver enzymes may change medroxyprogesterone exposure, and hormone therapy can affect the interpretation of some laboratory tests. The interaction significance depends on the exact medicine and dose. Do not assume that a supplement or herbal product is harmless with hormonal therapy.

Patients should buy Cycrin only from a pharmacy that can perform an interaction review and provide the correct product. Cycrin price is a practical concern to raise with the pharmacy, but changes to hormone therapy, estrogen use, or the dosing schedule require the prescriber's directions.

Medical disclaimer: This content is for informational purposes only and does not replace advice, diagnosis, or treatment from a licensed healthcare professional. It is not a substitute for approved prescribing information or emergency care. Patients should follow their prescriber's directions and consult their healthcare professional about personal medical decisions, symptoms, medicines, monitoring, and treatment changes.